methylphenidate has been researched along with Asthma in 7 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| " It has been known to have side effects such as dyskinesia, but this case details the emergence of dystonia and dyskinesia when the simultaneous use of methylphenidate and a phenothiazine was followed by withdrawal of the phenothiazine." | 7.66 | Methylphenidate, neuroleptics and dyskinesia-dystonia. ( Chapel, J; Husain, A; Malek-Ahmadi, P, 1980) |
| " It has been known to have side effects such as dyskinesia, but this case details the emergence of dystonia and dyskinesia when the simultaneous use of methylphenidate and a phenothiazine was followed by withdrawal of the phenothiazine." | 3.66 | Methylphenidate, neuroleptics and dyskinesia-dystonia. ( Chapel, J; Husain, A; Malek-Ahmadi, P, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Schans, J | 1 |
| Pleiter, JC | 1 |
| de Vries, TW | 1 |
| Schuiling-Veninga, CC | 1 |
| Bos, JH | 1 |
| Hoekstra, PJ | 1 |
| Hak, E | 1 |
| SCHILLER, IW | 1 |
| FONTAN BALESTRA, E | 1 |
| DREYFUS, S | 1 |
| TOOGOOD, JH | 1 |
| Husain, A | 1 |
| Chapel, J | 1 |
| Malek-Ahmadi, P | 1 |
| Abbott, MB | 1 |
| Levin, RH | 1 |
1 review available for methylphenidate and Asthma
| Article | Year |
|---|---|
What's new: newly approved drugs for children.
Topics: Adolescent; Age Factors; Albuterol; Androstadienes; Anticonvulsants; Asthma; Atovaquone; Attention D | 2001 |
6 other studies available for methylphenidate and Asthma
| Article | Year |
|---|---|
Association between medication prescription for atopic diseases and attention-deficit/hyperactivity disorder.
Topics: Anti-Allergic Agents; Asthma; Attention Deficit Disorder with Hyperactivity; Case-Control Studies; C | 2016 |
Experience with methylphenidate hydrochloride (ritalin).
Topics: Asthma; Humans; Hyperthermia, Induced; Methylphenidate; Rhinitis, Allergic, Seasonal | 1958 |
[Asthma and depression. Treatment with methylphenidylacetate].
Topics: Asthma; Depression; Depressive Disorder; Methylphenidate | 1961 |
[The spasmolytic effect of pyribenzamine-ritalin as an admixture to inhalation of hydrogen sulfide-containing mineral springs].
Topics: Asthma; Humans; Hydrogen Sulfide; Methylphenidate; Mineral Waters; Minerals; Parasympatholytics; Res | 1962 |
Betamethasone in the treatment of bronchial asthma.
Topics: Asthma; Betamethasone; Humans; Methylphenidate | 1962 |
Methylphenidate, neuroleptics and dyskinesia-dystonia.
Topics: Asthma; Child, Preschool; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Dystonia; Humans; Hyp | 1980 |